NASHVILLE, Tenn., Sept. 26, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it has entered into an ...
NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, announced results for the third quarter and nine months ended September 30, 2024. The ...
Hosted on MSN
Harrow To Acquire Sedation Solutions Developer Melt Pharmaceuticals – More Details Inside
Harrow (HROW) announced on Friday that it has entered into an agreement to acquire privately held Melt Pharmaceuticals for an undisclosed price. While Harrow is a provider of ophthalmic disease ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback